Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$25.12 - $55.75
Next Earnings Date
May 06 2025
Next Earnings Date
May 06 2025
Latest price
Market Cap | $1.44B |
EV | $1.45B |
Shares Outstanding | 46.84M |
Beta | 0.79 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | $50.71 |
P/E 2025E | 17.37x |
P/Revenue 2025E | 1.27x |
Revenue | -0.60% |
EPS | -23.40% |
Operating Cash Flow | -6.90% |
Free Cash Flow | -9.30% |
Revenue | 4.10% |
EPS | 6.60% |
Operating Cash Flow | -4.20% |
Free Cash Flow | -16.70% |
Gross Margin 2025E | 43.47% |
Net Profit Margin 2025E | 2.17% |
ROE 2025E | 6.73% |
ROCE 2024 | 1.03% |
DPS 2025E | $0.00 |
Payout Ratio 2025E | 0.00% |
Div. Yield 2025E | 0.00% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Omnicell, Inc.
OMCL
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Lipps, Randall
Employees
3,670
Website
www.omnicell.comIPO Date
2001-08-09
Headquarters
4220 North Freeway, Suite 301, Fort Worth, Texas, 76137, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved